Alkhaleej Alsharqi
Healthcare & Pharmaceutical Distribution Platform in Libya
Established in 2011, Alkhaleej Alsharqi is a healthcare and pharmaceutical distribution company headquartered in Tripoli, Libya.
The company operates under Alkhaleej Group, which forms part of Alnakeel Holding Company — a diversified holding group with business interests across healthcare, food, consumer products, trading, real estate, banking, and other strategic sectors.
Within this broader structure, Alkhaleej Alsharqi serves as the group’s dedicated healthcare and pharmaceutical platform, responsible for pharmaceutical distribution, market development, healthcare supply chain support, and strategic portfolio expansion across the Libyan market.
Key Figures
Established: 2011
Market Coverage: 3,000+ healthcare & retail points
Operational Reach: Nationwide Libya
Group Workforce: 350+ employees
Corporate Overview
Since its establishment, the company has built a strong market reputation through reliable execution, disciplined commercial development, and long-term partnerships with hospitals, clinics, pharmacies, wholesalers, and healthcare institutions across Libya.
Over the years, Alkhaleej Alsharqi has evolved from a conventional distributor into a structured healthcare platform focused on sustainable growth, professional market access, and long-term value creation.
Market Presence
Alkhaleej Alsharqi maintains broad national market access across Libya through an established commercial and distribution network serving more than 3,000 healthcare and retail points nationwide.
Its market reach covers both institutional and private-sector healthcare channels, supported by regional agents, strategic partners, and strong customer relationships throughout the country.
Facilities & Distribution Capability
To support nationwide operations, the company maintains multiple warehouse facilities in Tripoli, Zliten, and Zawiya, in addition to shared warehousing capacity with the parent group in Benghazi.
This operational footprint supports efficient product movement, supply continuity, and responsive service across both retail and institutional healthcare markets.
Organizational Strength
As part of Alnakeel Holding Company, the wider group includes more than 350 employees across affiliated companies.
Alkhaleej Alsharqi combines strong local market knowledge with professional execution capabilities through a multidisciplinary team covering commercial operations, regulatory affairs, procurement, logistics and supply chain, finance, medical promotion, and scientific marketing.
The company also maintains a specialized field force composed of medical representatives, pharmaceutical professionals, physicians, and product specialists, enabling strong scientific communication, effective product positioning, and deep market penetration across Libya.
Current Product Portfolio
- Bambo Nature — premium baby care and eco-friendly diapers
- ABENA — adult care, hygiene, and healthcare solutions
- Noumed (UK) — pharmaceutical products
- Microcyn & Dermacyn- USA — advanced wound care and infection management solutions
- Venus International / Venus Remedies / Venus Pharma GmbH Germany — injectable and specialized pharmaceutical portfolio
- Medical disposables and hospital consumables
- Medical equipment, healthcare furniture, oxygen therapy, .
- Orthopedic footwear and orthopedic support products
Strategic Expansion & Future Direction
As part of its long-term growth strategy, Alkhaleej Alsharqi is actively pursuing future partnerships and portfolio expansion across specialized pharmaceutical and consumer healthcare segments.
- Haver Pharmaceutical (Turkey) — injectable pharmaceutical collaboration under evaluation
- Cipla — pharmaceutical partnership opportunity in respiratory range
- Church & Dwight — future introduction of personal care and household healthcare brands including Arm & Hammer
Over the coming period, the company will focus on expanding specialty pharmaceutical products, injectable pharmaceutical portfolios, hospital-based therapies, institutional healthcare products, general pharmaceutical products, and oncology and critical care therapeutic segments.
The long-term objective is to strengthen Alkhaleej Alsharqi’s position as one of Libya’s most trusted and comprehensive healthcare distribution platforms, built on reliable execution, broad market access, high-quality portfolios, and sustainable international partnerships.